| RS201967266 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS201967384 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucose-6-phosphate transport defect, Inborn genetic diseases |
| RS201967733 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201967801 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201968272 |
DDX11
|
Health Risk |
Pathogenic/Likely pathogenic |
Warsaw breakage syndrome, Sarcoma |
| RS201968725 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Occult macular dystrophy |
| RS201968775 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 4 |
| RS201968826 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Dilated cardiomyopathy 1C |
| RS2019693030 |
NACC1
|
Health Risk |
Likely pathogenic |
— |
| RS201970174 |
MATR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 21, MATR3-related disorder |
| RS201970407 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS201970483 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS201970522 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS201970559 |
NRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2019706242 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with epilepsy, cataracts |
| RS201970806 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS201970872 |
ARHGAP31
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201970876 |
FANCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group E, Inborn genetic diseases |
| RS201971047 |
OAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201971084 |
USP48
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 85 |
| RS201971114 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Monogenic diabetes |
| RS201971363 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Malignant hyperthermia |
| RS201971682 |
MYOZ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 16, Cardiovascular phenotype |
| RS201971718 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS201971987 |
TXNRD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Primary dilated cardiomyopathy |
| RS201972673 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS201972783 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rafiq syndrome |
| RS201972896 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Charcot-Marie-Tooth disease dominant intermediate B |
| RS201973611 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS2019737049 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201973949 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS201974522 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS201974671 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201975029 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-related disorder |
| RS201975081 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, MYPN-related myopathy |
| RS201975130 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS201975160 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201975537 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS201975697 |
OSMR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201975812 |
DNASE1
|
Health Risk |
Conflicting classifications of pathogenicity |
DNASE1-related disorder, DNASE1-related disorder |
| RS201976061 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 45 |
| RS201976136 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS201976154 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS201976178 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryopyrin associated periodic syndrome, Autoinflammatory syndrome |
| RS201976186 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS201976983 |
CLCN2
|
Health Risk |
Pathogenic/Likely pathogenic |
CLCN2-related disorder, CLCN2-related disorder |
| RS201977288 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS201977551 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS201977682 |
TOP1MT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201978086 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Congestive heart failure |
| RS201978087 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spastic paraplegia |
| RS201978396 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS201978571 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 3 |
| RS201978662 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS201978719 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS201978870 |
ODAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201979002 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201979180 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS201979237 |
ARHGAP24
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201979258 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phytanic acid storage disease, Inborn genetic diseases |
| RS201979319 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
Otitis media, susceptibility to |
| RS201979610 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS201979616 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS201979629 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 13A (Zellweger), Peroxisome biogenesis disorder |
| RS201979656 |
HERC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201980005 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Inborn genetic diseases |
| RS201980317 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201980416 |
AMPD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocyte AMP deaminase deficiency, Erythrocyte AMP deaminase deficiency |
| RS201980470 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS201980471 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS201980874 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, Inborn genetic diseases |
| RS201981364 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS201981625 |
ZFPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201982602 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Complex neurodevelopmental disorder, Intellectual disability |
| RS201983356 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201983374 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201983595 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201983881 |
SH3BP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrous dysplasia of jaw, Inborn genetic diseases |
| RS201984003 |
PGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 42 |
| RS201984007 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Paroxysmal extreme pain disorder, Primary erythromelalgia |
| RS201984297 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS201984572 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS201984824 |
CKAP2L
|
Health Risk |
Pathogenic |
Filippi syndrome, Filippi syndrome |
| RS201984825 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201984924 |
PRPF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, PRPF6-related disorder |
| RS201985073 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS201985170 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome, type 5 |
| RS201985242 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS201985394 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4C |
| RS201985838 |
MAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 75, Hereditary spastic paraplegia 75 |
| RS201985951 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS201985955 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Dilated cardiomyopathy 1J |
| RS201986299 |
DNAAF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201986472 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS201986622 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS201986784 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201987018 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS201987106 |
NPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201987555 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS201987672 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, SDHD-related disorder |